{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:26:43Z","timestamp":1792762003827,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI115703"],"award-info":[{"award-number":["AI115703"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI116658"],"award-info":[{"award-number":["AI116658"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaci.2021.02.038","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T19:35:21Z","timestamp":1615404921000},"page":"2271-2280.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes"],"prefix":"10.1016","volume":"147","author":[{"given":"Kirti J.","family":"Johal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly C.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja P.","family":"Bieneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Donald W.","family":"MacGlashan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbjit S.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.02.038_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.iac.2013.09.012","article-title":"Chronic spontaneous urticaria: etiology and pathogenesis","volume":"34","author":"Saini","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2021.02.038_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mai.2002.123236","article-title":"TH1\/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction","volume":"109","author":"Ying","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11882-009-0040-3","article-title":"Basophil responsiveness in chronic urticaria","volume":"9","author":"Saini","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2021.02.038_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1398-9995.1961.tb02894.x","article-title":"Basopenia in urticaria","volume":"16","author":"Rorsman","year":"1961","journal-title":"Acta Allergol"},{"key":"10.1016\/j.jaci.2021.02.038_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2222.2003.01589.x","article-title":"Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity","volume":"33","author":"Grattan","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.02.038_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaip.2019.08.004","article-title":"Association of basophil parameters with disease severity and duration in chronic spontaneous urticaria (CSU)","volume":"8","author":"Huang","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.02.038_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/all.12578","article-title":"Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria","volume":"70","author":"Oliver","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.02.038_bib8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1398-9995.2011.02570.x","article-title":"Basophil recruitment and activation in inflammatory skin diseases","volume":"66","author":"Ito","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.02.038_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2222.1974.tb01384.x","article-title":"Serum and cell bound IgE in chronic urticaria","volume":"4","author":"Greaves","year":"1974","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaci.2021.02.038_bib10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI108405","article-title":"Defective histamine release in chronic urticaria","volume":"57","author":"Kern","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2021.02.038_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2006.09.035","article-title":"Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria","volume":"119","author":"Vonakis","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib12","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/all.13215","article-title":"Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria","volume":"72","author":"Rauber","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.02.038_bib13","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/jid.2008.55","article-title":"Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies","volume":"128","author":"Eckman","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2021.02.038_bib14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13601-017-0141-3","article-title":"Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria","volume":"7","author":"van den Elzen","year":"2017","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2021.02.038_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2004.06.032","article-title":"Omalizumab-induced reductions in mast cell Fce psilon RI expression and function","volume":"114","author":"Beck","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib17","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Down-regulation of FceRI expression on human basophils during in\u00a0vivo treatment of atopic patients with anti-IgE antibody","volume":"158","author":"MacGlashan","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaci.2015.08.023","article-title":"Timing and duration of omalizumab response in patients with chronic idiopathic\/spontaneous urticaria","volume":"137","author":"Kaplan","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/all.13083","article-title":"Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria","volume":"72","author":"Kaplan","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.02.038_bib20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaip.2017.10.030","article-title":"Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria","volume":"6","author":"Straesser","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.02.038_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/all.13345","article-title":"The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change","volume":"73","author":"Ertas","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.02.038_bib22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2340\/00015555-2654","article-title":"Basophil FcepsilonRI expression in chronic spontaneous urticaria: a potential immunological predictor of response to omalizumab therapy","volume":"97","author":"Deza","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2021.02.038_bib23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2016.07.047","article-title":"Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria","volume":"139","author":"Gericke","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaip.2015.11.025","article-title":"Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria","volume":"4","author":"Palacios","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.02.038_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaci.2009.09.012","article-title":"Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge","volume":"125","author":"Eckman","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib26","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2012.05.039","article-title":"Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy","volume":"130","author":"Savage","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/jid.2013.541","article-title":"Differences in effects of omalizumab on late-phase responses to allergen challenge in the skin and nose at the time of basophil hyporesponsiveness","volume":"134","author":"Paterniti","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2021.02.038_bib28","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.7150\/thno.18304","article-title":"Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcepsilonRI-positive cells in the skin","volume":"7","author":"Metz","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jaci.2021.02.038_bib29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2009.10.021","article-title":"Decreases in human dendritic cell-dependent T(H)2-like responses after acute in\u00a0vivo IgE neutralization","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.anai.2011.09.008","article-title":"Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria","volume":"108","author":"Mathias","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib31","doi-asserted-by":"crossref","first-page":"7.24.1","DOI":"10.1002\/0471142735.im0724s112","article-title":"Isolation of human basophils","volume":"112","author":"Schroeder","year":"2016","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib32","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.4049\/jimmunol.175.9.5724","article-title":"TLR9- and Fc{epsilon}RI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression","volume":"175","author":"Schroeder","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib33","doi-asserted-by":"crossref","unstructured":"MacGlashan D Jr, Saini S, Schroeder JT. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab. J Allergy Clin Immunol [E-pub ahead of print]. March 12, 2021. https:\/\/doi.org\/10.1016\/j.jaci.2021.02.039.","DOI":"10.1016\/j.jaci.2021.02.039"},{"key":"10.1016\/j.jaci.2021.02.038_bib34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cea.13566","article-title":"Response of FcepsilonRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria","volume":"50","author":"Alizadeh Aghdam","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.02.038_bib35","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.jaci.2016.12.965","article-title":"Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab","volume":"139","author":"MacGlashan","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib36","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/jdv.16216","article-title":"Omalizumab response correlates with reduced IFN-gamma-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria","volume":"34","author":"Rauber","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2021.02.038_bib37","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1365-2133.2010.10198.x","article-title":"Impaired IFN-alpha secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria","volume":"164","author":"Futata","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2021.02.038_bib38","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2015.09.008","article-title":"Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations","volume":"136","author":"Teach","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.02.038_bib39","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jid.2016.11.025","article-title":"Effect of omalizumab on blood basophil counts in patients with chronic idiopathic\/spontaneous urticaria","volume":"137","author":"Saini","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2021.02.038_bib40","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0091-6749(79)90217-3","article-title":"Early effects of corticosteroids on basophils, leukocyte histamine and tissue histamine","volume":"63","author":"Dunsky","year":"1979","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921003717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921003717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:30:33Z","timestamp":1758792633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921003717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0091674921003717"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.02.038","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739739475.793584404","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}